The global rare haematology disorders market is anticipated to grow at a CAGR of 5.6% during the forecast period of 2024-2032. Rare haematology disorders, though affecting a small portion of the population, are significant in terms of medical needs and treatment advancements. This market encompasses a range of rare blood-related conditions, including Haemophilia, Sickle Cell Disease (SCD),...